Author:
Jo Yumin,Oh Chahyun,Lee Woo-Yong,Lee Donggeun,Shin Suyeon,Chung Woosuk,Lim Chaeseong,Lee Sun Yeul,Hong Boohwi
Abstract
BACKGROUND
Inter-scalene block (ISB) is associated with an inevitable risk of hemi-diaphragmatic paresis (HDP). To reduce the risk of HDP, an upper trunk block (UTB) has been proposed at the brachial plexus division level.
OBJECTIVE
We hypothesised that UTB would be associated with a lower incidence of HDP than ISB while providing sufficient analgesia following arthroscopic shoulder surgery.
DESIGN
Randomised controlled trial.
SETTING
A tertiary teaching hospital.
PATIENTS
Seventy patients aged 20 to 80 years undergoing arthroscopic rotator cuff repair.
INTERVENTION
Ultrasound-guided ISB or UTB was performed with 5 ml 0.75% ropivacaine.
MAIN OUTCOME MEASURES
The primary outcome was the incidence of complete HDP, assessed by diaphragm excursion using ultrasound, defined as a decrease to 25% or less of baseline or occurrence of paradoxical movement. Postoperative pulmonary function change, pain scores, opioid consumption and pain-related outcomes were the secondary outcomes.
RESULTS
The UTB group had a significantly lower incidence of complete HDP than the ISB group [5.9% (2/34) vs. 41.7% (15/36); absolute difference, 35.8%; 95% confidence interval (CI), 17.8 to 53.7%; P < 0.001]. The postblockade decline in pulmonary function was more pronounced in the ISB group than that in the UTB group. The pain score at 1 h postoperatively was not significantly different between the groups (ISB vs. UTB group: median 0 vs. 1; median difference, −1; 95% CI, −2 to 0.5). No significant difference was observed in any other secondary outcomes.
CONCLUSION
UTB was associated with a lower incidence of HDP compared with ISB while providing excellent analgesia in arthroscopic shoulder surgery.
TRIAL REGISTRATION
Clinical Trial Registry of Korea (https://cris.nih.go.kr) identifier: KCT0007002.
IRB NUMBER
Chungnam National University Hospital Institutional Review Board No. 2021-12-069.
Publisher
Ovid Technologies (Wolters Kluwer Health)